Overview
Hiroko Murata practices practicing medicine in Hirakata, Japan.
Her clinical expertise encompasses B-Cell Lymphoma and Diffuse Large B-Cell Lymphoma (DLBCL).
She is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hiroko Murata
Is Hiroko Murata a top-rated expert for B-Cell Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Hiroko Murata is classified as an Experienced expert for B-Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hiroko Murata participate in research or clinical trials?
Yes. Hiroko Murata has published 10 articles and abstracts on conditions like B-Cell Lymphoma. You can view a list of Hiroko Murata's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- B-Cell LymphomaMs. Murata isExperienced. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Ms. Murata isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).